Complement-dependent modulation of antitumor immunity following radiation therapy

Area of Science:

• Immunology
• Oncology
• Radiotherapy

Background:

• Complement traditionally viewed as pro-inflammatory in antitumor immunity.
• Complement also plays a role in clearing apoptotic cells, which can be tolerogenic.

Purpose of the Study:

• To investigate the role of complement in radiation therapy (RT) for murine lymphoma.
• To evaluate the efficacy of tumor-targeted complement inhibition when combined with RT.

Main Methods:

• Localized fractionated radiation therapy (RT) on subcutaneous murine lymphoma.
• Administration of tumor-targeted complement inhibition.
• Analysis of apoptotic cell numbers, inflammation, neutrophil influx, dendritic cell maturation, and T-cell immunity.

Main Results:

• RT induced tumor cell apoptosis and local complement activation.
• Complement inhibition significantly improved RT therapeutic outcomes.
• Improved outcomes correlated with increased early apoptotic cells, inflammation, and neutrophil influx.
• Enhanced dendritic cell maturation and modulated T-cell immunity were observed.

Conclusions:

• Targeted complement inhibition can enhance the efficacy of radiation therapy for cancer.
• This strategy leverages early apoptotic cell clearance and modulates the immune response for improved antitumor effects.